Other OTC - Delayed Quote USD

Therapeutic Solutions International, Inc. (TSOI)

0.0005

-0.0001

(-8.33%)

At close: 3:47 PM EDT

No Tool

Measure

UNDO

Redo

All

Favorites

Text

Statistics

Technicals

Fibonacci

Markings

Lines

Annotation

Arrow

Line

Horizontal

Vertical

Rectangle

Trend Line

Measurement Line

Average Line

Callout

Channel

Check

Continuous

Crossline

Elliott Wave

Ellipse

Doodle

Fib Projection

Fib Arc

Fib Fan

Fib Time Zone

Focus

Gann Fan

Gartley

Heart

Pitchfork

Quadrant Lines

Ray

Regression Line

Fib Retracement

Star

Speed Resistance Arc

Speed Resistance Line

Time Cycle

Tirone Levels

Volume Profile

Cross

Loading Chart for TSOI

Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients

Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product

Therapeutic Solutions International Files Patent on "Facilitating Effects" of JadiCells on Gene Therapy Mediated Cell Differentiation

Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities

Therapeutic Solutions International Launches Adult Stem Cell Therapy Company Focused on Curing Epilepsy

Therapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene™

Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease

Therapeutic Solutions International and Campbell Neurosciences Publish on Nutritional Modulation of the Indolamine 2,3 Dioxygenase Pathway as a Non-Toxic Means of Addressing Depression

Therapeutic Solutions International Collaborates on Peer-Reviewed Publication on Personalized Immunotherapy for Brain Cancer Using mRNA

Res Nova Biologics Announces First Cancer Patient Treated with FloraStilbene™

Res Nova Biologics Recruits Abortion Pill Reversal Founder to Scientific Advisory Board

Therapeutic Solutions International Announces Paradigm Shifting Immunotherapy Product: Tolerogenic Neutrophils

CELZ Creative Medical Technology Holdings, Inc.

4.4000

-8.81%

ENZC Enzolytics, Inc.

0.0044

+2.33%

RGBP Regen BioPharma, Inc.

0.7400

0.00%

ENDV Endonovo Therapeutics, Inc.

0.0024

-4.00%

TXTM ProText Mobility, Inc.

0.0018

-21.74%

BRTX BioRestorative Therapies, Inc.

1.2300

-3.15%

KTTA Pasithea Therapeutics Corp.

7.24

+3.43%

IUGNF Imugene Limited

0.0528

+0.57%

VRAX Virax Biolabs Group Limited

0.7000

+7.53%

NWBO Northwest Biotherapeutics, Inc.

0.4770

+3.67%

Date
Close
Open
High
Low
Volume

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance